Radiopharm reports partial response in RAD204 cancer trial

Markets Investing.com By Investing.com 22 Jul 2026 11:12 1 min read

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.